用户名: 密   码:
注册 | 忘记密码?
专利信息
查询条件 展开筛选条件
  • [药品] 包含 'Tazarotene'
排序 翻到页码
标题标题2专利权人发明人附图摘要摘要2优先权号IPC专利类型
首页123456下页尾页64 条记录, 当前第1/7页。
公开号 公开日 申请号 申请日
1. AU2012275714A1 2014/1/30 AU20120275714 2012/6/22
专利标题:Retinoid topical compositions and methods for treating skin conditions 法律状态
专利权人ALLERGAN INC;
A topical pharmaceutical composition comprising tazarotene and one or more of an anti-inflammatory or anti-bacterial agent. Also provided is a method for treating skin conditions, such as acne utilizing the above topical pharmaceutical composition.


2. AU2012272642A1 2014/1/30 AU20120272642 2012/6/22
专利标题:Prevention and treatment of inflammatory conditions 法律状态
专利权人GLYCOREGIMMUNE INC;
The present embodiments relate to methods for the prevention and treatment of inflammatory conditions such as alcoholic liver disease (ALD). More specifically the present embodiments relate to the prevention and treatment of ALD through the administration of an Retinoic Acid Receptor (RAR) agonist. Some embodiments relate to use of tazarotene in the prevention and treatment of alcohol-induced liver injury, alcohol-related liver disease, fatty liver disease, hepatic steatosis, alcoholic hepatitis...


3. CN103405781A 2013/11/27 CN20131374296 2013/8/26
专利标题:Pharmaceutical composition of compound clindamycin and tazarotene lipid complex 法律状态


4. NZ598240A 2013/10/25 NZ20100598240 2010/7/16
专利标题:TAZAROTENE DERIVATIVES 法律状态
专利权人STIEFEL LABORATORIES;
Abstract 598240 The presently described subject matter relates to new derivatives of tazarotene that also exhibit retinoid activity, pharmaceutical compositions comprising the derivatives, pharmaceutical use for treating skin disorders with the pharmaceutical compositions, and process of making the derivatives. Compounds of the disclosure include: 6-[(4,4-dimethyl-2-(pyridine-3-carbonyloxy)thiochroman-6-yl)ethynyl]nicotinic acid ethyl ester, Ethyl 6-[2-(2-(dodecanoylozy)-4,4-dimethyl-thiochroman...


5. AU2010273261B2 2013/7/25
专利标题:Tazarotene derivatives 法律状态
The presently described subject matter relates to new derivatives of tazarotene that also exhibit retinoid activity pharmaceutical compositions comprising the derivatives method of treating skin disorders with the pharmaceutical compositions and process of making the derivatives.


6. CN102988987A 2013/3/27 CN20121539097 2012/12/13
专利标题:Pharmaceutical composition for treating hyperproliferative skin disease and preparation of pharmaceutical composition 法律状态


7. US2013045932A1 2013/2/21 US201213530468 2012/6/22
专利标题:RETINOID TOPICAL COMPOSITIONS AND METHODS FOR TREATING SKIN CONDITIONS 法律状态
A topical pharmaceutical composition comprising tazarotene and one or more of an anti-inflammatory or anti-bacterial agent. Also provided is a method for treating skin conditions, such as acne utilizing the above topical pharmaceutical composition.


8. CA2840733A1 2013/1/3 CA20122840733 2012/6/22
专利标题:RETINOID TOPICAL COMPOSITIONS AND METHODS FOR TREATING SKIN CONDITIONS 法律状态
专利权人ALLERGAN INC [US];
A topical pharmaceutical composition comprising tazarotene and one or more of an anti-inflammatory or anti-bacterial agent. Also provided is a method for treating skin conditions, such as acne utilizing the above topical pharmaceutical composition.


9. WO2013003236A1 2013/1/3 WO2012US43833 2012/6/22
专利标题:RETINOID TOPICAL COMPOSITIONS AND METHODS FOR TREATING SKIN CONDITIONS 法律状态
A topical pharmaceutical composition comprising tazarotene and one or more of an anti-inflammatory or anti-bacterial agent. Also provided is a method for treating skin conditions, such as acne utilizing the above topical pharmaceutical composition.


10. CA2840272A1 2012/12/27 CA20122840272 2012/6/22
专利标题:PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS 法律状态
专利权人GLYCOREGIMMUNE INC [US];
The present embodiments relate to methods for the prevention and treatment of inflammatory conditions such as alcoholic liver disease (ALD). More specifically the present embodiments relate to the prevention and treatment of ALD through the administration of an Retinoic Acid Receptor (RAR) agonist. Some embodiments relate to use of tazarotene in the prevention and treatment of alcohol-induced liver injury, alcohol-related liver disease, fatty liver disease, hepatic steatosis, alcoholic hepatitis...



首页123456下页尾页64 条记录, 当前第1/7页。

下载范围

下载第 条记录。

下载内容

题录信息 专利全文